BIEI OTC
Premier Biomedical, Inc.
1W: +10.0%
1M: -8.3%
3M: -15.4%
YTD: +10.0%
1Y: -31.2%
3Y: -31.2%
5Y: -83.8%
$0.00
-0.00 (-8.33%)
Weekly Expected Move ±26.3%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$171K
-5928.0% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$171K
-5928.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$4K
+43.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$374K | -$403K | -$39K | -$49K | -$202K |
| Depreciation & Amort. | $3K | $2K | $1K | $1K | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $52K | $67K | $32K | $48K | $31K |
| Other Non-Cash Items | -$25K | $263K | $0 | $3K | $0 |
| Operating Cash Flow | -$344K | -$71K | -$5K | $3K | -$171K |
| — Investing Activities — | |||||
| Capital Expenditures | -$5K | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$5K | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $333K | $0 | $5K | $0 | $175K |
| Financing Cash Flow | $333K | $0 | $5K | $0 | $175K |
| Net Change in Cash | -$16K | -$71K | $0 | $3K | $4K |
| Cash End of Period | $71K | $0 | $0 | $3K | $4K |
| Free Cash Flow | -$349K | -$71K | -$5K | $3K | -$171K |